Catalyst Wire Dossier Catalyst Wire Dossier

Cerogrin

· Neurogrin Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cerogrin, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment [NA]

See pricing